Anxiety, Depression and Self-Efficacy in Patients with Myasthenia Gravis

  1. Pamela Parada
  2. Mireia Oliva
  3. Esther Lázaro
  4. Imanol Amayra
  5. Juan Francisco López Paz
  6. Oscar Martínez
  7. Amaia Jometén
  8. Sarah Berrocoso
  9. Andrea Iglesias
  10. Manuel Pérez
  11. José Eulalio Bárcena
Revista:
International journal of psychology and psychological therapy

ISSN: 1577-7057

Any de publicació: 2014

Volum: 14

Número: 3

Pàgines: 105-113

Tipus: Article

DIALNET GOOGLE SCHOLAR

Altres publicacions en: International journal of psychology and psychological therapy

Resum

Myasthenia is an autoimmune disease of neuromuscular transmission. This disease is typically characterised by muscle weakness, which is exacerbated by the performance of certain activities or exercise; patients usually recover with rest. Some studies have noted that people with myasthenia gravis have significantly higher depression scores than control participants. Extended experience with neuromuscular disease symptoms has been correlated with mood disorder symptoms. The present study measured and compared the presence of depression, anxiety and self-efficacy as well as the relationships among these variables in people with myasthenia gravis. An evaluation scale for this disease was specifically adapted. A total of 52 participants with myasthenia gravis were given two tests: the HAD questionnaire, which measures depression, and the general self-efficacy questionnaire (GSE). This study found a significantly correlation between anxiety and depression in people with myasthenia gravis. A correlation between self-efficacy and depression was also observed

Referències bibliogràfiques

  • Baral I (2007). Mood an anxiety disorders in patients with myasthenia gravis: Etiology, diagnosis and treatment. CNS Drugs, 21, 473- 481.
  • Baessler J & Schwarcer R (1996). Evaluación de la autoeficacia: Adaptación española de la escala de Autoeficacia General. Ansiedad y Estrés, 2, 1-8.
  • Calle A, Simoes M, De Figueiredo G, & Muriano G (2011). Myasthenia gravis. Two cose reports and review of literatura. Brazilian Journal of Anesthesiology, 61, 748-763. doi 10.1016/S0034-7094(11)70084-8.
  • Castro MMV, Guarantini L, Batista-Neves S, Kraychete DC, & Miranda-Scippa A (2006). Validez de la Escala Hospitalaria de Ansiedad y Depresión en Pacientes con Dolor Crónico. Revista Brasileira de Anestesiología, 56, 314-318.
  • Chienza J, Fleming I, Parry N, & Skelton V (2010). Maternal myasthenia gravis, complicated by fetal artrogryposis multiplex congenital. International Journal of Obstetric Anesthesia, 20, 79-82.
  • Donald B, Sanders, F, & Howard J (1991). Disorders of neuromuscular transmission. Neurology in Clinical Practice, 2, 2441-2461.
  • García T, Villalobos J, & Rodríguez H (2011). Miastenia gravis: caso clínico y revisión de la bibliografía. [Myasthenia gravis: case report and review of the literature.]. Medicina Interna de México, 27, 299-309.
  • Herrmann C (1997). International Experiences with the Hospital Anxiety and Depression Scale-A Review of Validation Data and Clinical Results. Journal of Psychosomatic Research, 1, 42, 17-41.
  • Lázaro E, Amayra I, López Paz J, Martín N, Caballero P, De Nicolás L, Hoffman H, Kessler H, Ruiz B, & Martínez O (2011). Facial affect recognition in myasthenia gravis Neuromuscular Disorders. 21, 639-751.
  • Lázaro E, Amayra I, López Paz, JF, Jometón A, Pérez M, & Oliva M (2013). E-motion1.0: a Virtual Serious Game to assess Theory of Mind in children. IADIS International Conference e-Society 2013. Lazarus RS & Folkman S (1984). Strees, Appraisal and Coping. New York: Springer.
  • Leppänen JM, Milders M, Bell JS, Terriere E, & Hietanen JK (2004). Depression biases the recognition of emotionally neutral faces. Psychiatry Research, 128, 123-133.
  • López Roig S, Terol MC, Pastor MA, Neipp MC, Massutí B, Rodríguez Marín J, Leyda JI, Martín Aragón M, & Sitges E (2000). Ansiedad y Depresión. Validación de la escala HAD en pacientes oncológicos. Revista de Psicología de la Salud, 12, 127-155.
  • Martín N (2010). Programa online de mejora de habilidades sociales y emocionales para personas diagnosticas de miastenia gravis. Tesis doctoral no publicada. Universidad de Valladolid. Valladolid, España.
  • Moreira M, Lucas Q, Batista Neves S, Campos K, Daltro C, & Miranda Scippa A (2006). Validez de la escala hospitalaria de ansiedad y depresión en pacientes con dolor crónico. Revista Brasileira de Anesteiología,56, 314-318.
  • Muñoz C, Díez E, Frank A, Pino J, Pérez C, & Barreiro P (2004). Evaluation of maximal respiratory pressures in myasthenia gravis. European Neurology, 52, 136-140. doi: 10.1159/000081464
  • Ochs C, Bradley R, Katholi C, Byl N, Brown V, Jones L, & Shohet J (1998). Symptoms of patients with myasthenia gravis receiving treatment. Journal Medical, 29, 1-12.
  • Pallaver F, Riviera A, Piffer S, Ricciardi R, Roni R, Orrico D, & Bonifati D (2010). Change in myasthenia gravis epidemiology in Trento, Italy, after twenty years. Neuroepidemiology, 36, 282- 287. doi:10.1159/000328863
  • Paul R, Cohen R, Gilchrist J, & Goldstein J (2000a). Fatigue and its impact on patients with myasthenia gravis. Muscle and Nerve, 23, 1402-1406. http://www. ijpsy. com © International Journal of Psychology & Psychological Therapy, 2014, 14, 1 Mood disorders and Myasthenia Gravis 113
  • Paul R, Cohen R, Golsdtein J, & Gilchrist J (2000b). Severity of mood, self- evaluative, and vegetative symptoms of depression in myasthenia gravis. Journal Neuropsychiatry Clinical Neuroscience, 12, 499-501.
  • Phillips L (1994). The epidemiology of myasthenia gravis. Neurology Clinics of North America, 2, 263- 271.
  • Robert H, Ronal A, Jonathan M, & James M (2000). Evaluative and vegetative symptoms of depression in myasthenia gravis. The Journal of neuropsychiatry and clinical neurosciences, 12, 499-501.
  • Sanjuán P, Pérez AM, & Bermúdez J (2000). Escala de autoeficacia general: Datos psicométricos de la adaptación para población española. Psichothema, 12, 509-513.
  • Sitek E, Bilinska M, Wieczorek D, & Nyka W (2009). Neuropsychological assessment in myasthenia gravis. Neurological Science, 30, 9- 14. doi: 10.1007/s10072-008-0001-y.
  • Stewart S, Robertson K, Johnson K, & Howard J (2007). The prevalence of depression in myasthenia gravis. Journal Clinical Neuromuscular Disorder, 8, 111-115. doi: 10.1007/s10072-008-0001-y.
  • Terol MC, López Roig S, Rodríguez Marín J, Martín Aragón M, Pastor MA, & Reig MT (2007). Propiedades psicométricas de la Escala hospitalaria de Ansiedad y Depresión (HAD) en población española. Ansiedad y Estrés, 13, 163-176.
  • Thomann K & Pandya S (1995). Myasthenia grave: pathophysiology, diagnosis, differential diagnosis and management. Clinical Eye and Vision Care, 7, 3-13.
  • Ybarra M, Kummer A, Comini E, Oliveira J, Gómez R, & Texeira A (2011). Psychiatric Disorders in myasthenia gravis. Arquivos de Neuropsiquiatría, 69, 176- 179. doi:10.1590/S0004-282X2011000200006g.
  • Zigmond AS, & Snaith RP (1983). The Hospital Anxiety and Depression scale. Acta Psiquiatrica Scandinavica, 67, 361-370. doi: 04-282X2011000200006..
Fuente de los datos: Dialnet